1,438
Participants
Start Date
August 31, 2014
Primary Completion Date
February 28, 2019
Study Completion Date
February 28, 2019
Intervention
In intervention communities, management plans will be developed by the NPHW for all enrolled participants. The NPHWs will educate participants about CVD, HT treatment, lifestyle modifications and initiate therapy according to the modified WHO CVD risk-management algorithm, including referral of high-risk patients to physicians and safety monitoring where appropriate. Participants in intervention communities will have support from family or friends (treatment supporters) and will receive educational materials and treatment reminders using text-messaging, email, and printed materials, as appropriate for the participant and the community setting. Evidence-based CV medications will be made available to the NPHWs and supervising physicians for participant treatment.
Usual Care
At initial screening, eligible participants will be provided with a brief information booklet/leaflet (customized to the community or region) regarding lifestyle modification and be advised to see their usual physician for care that is considered appropriate. No structured interventions will be employed.
UniversitiTeknologi MARA (UiTM), Sungai Buloh
Simon Fraser University, Burnaby
Population Health Research Institute, Hamilton
FOSCAL, Floridablanca
Collaborators (1)
Population Health Research Institute
OTHER
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Grand Challenges Canada
OTHER
Global Alliance for Chronic Diseases (GACD)
OTHER
Hamilton Health Sciences Corporation
OTHER